The possible role of retinal dopaminergic system in visual performance

Neuroscience and Biobehavioral Reviews

Volumn 32, Issue 4, 2008, Pages 611-656

  Brandies, R ^a   Yehuda, S ^b  

^a ISRAEL INSTITUTE FOR BIOLOGICAL RESEARCH   (Israel)

^b BAR ILAN UNIVERSITY   (Israel)

Author keywords

Aging; DA augmentation; DA depletion; Dopamine; EFA deficiency; Parkinson; Schizophrenia; Visual performance

Indexed keywords

4,6,6A,7,8,12B HEXAHYDRO 7 METHYLINDOLO[4,3 AB]PHENANTHRIDINE; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; AMPHETAMINE; APOMORPHINE; CHLORPROMAZINE; DOPAMINE; DOPAMINE RECEPTOR; DOPAMINE RECEPTOR STIMULATING AGENT; FLUPHENAZINE; FLUPHENAZINE DECANOATE; FLUSPIRILENE; HALOPERIDOL; LEVODOPA; NOMIFENSINE; OXAZEPAM; PEMOLINE; PHENOTHIAZINE; PIMOZIDE; PLACEBO; QUINPIROLE; SULPIRIDE; TETRABENAZINE; THIORIDAZINE; TRIFLUOPERAZINE; TRIHEXYPHENIDYL;

ALZHEIMER DISEASE; AMBLYOPIA; CLINICAL TRIAL; COLOR DISCRIMINATION; CONTRAST SENSITIVITY; CRITICAL FLICKER FUSION; DOPAMINERGIC SYSTEM; DOSE RESPONSE; DRUG MECHANISM; ELECTRORETINOGRAPHY; ESSENTIAL FATTY ACID DEFICIENCY; EVOKED VISUAL RESPONSE; GILLES DE LA TOURETTE SYNDROME; HUMAN; LOW DRUG DOSE; MULTIPLE SCLEROSIS; NONHUMAN; PARKINSON DISEASE; PHENYLKETONURIA; PRIORITY JOURNAL; RECEPTIVE FIELD; RETINA MACULA AGE RELATED DEGENERATION; RETINITIS PIGMENTOSA; REVIEW; SCHIZOPHRENIA; SINGLE DRUG DOSE; TIC; VISUAL ACUITY; VISUAL DISORDER; VISUAL SYSTEM;

AGE FACTORS; ANIMALS; DOPAMINE; HUMANS; MELATONIN; RETINA; VISION DISORDERS; VISUAL PATHWAYS;

EID: 40149084032     PISSN: 01497634     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neubiorev.2007.09.004     Document Type: Review

References (234)

1. Adachi-Usami E. Senescence of visual function as studied by visually evoked cortical potentials. Japanese Journal of Ophthalmology 34 (1992) 81-94
2. Adachi-Usami E., Ikeda H., and Satoh H. Haloperidol delays visually evoked cortical potentials but not electroretinograms in mice. Journal of Ocular Pharmacology 6 (1990) 203-210
3. Agid Y., Ruberg M., Dubois B., Pillon B., Cusimano G., Raisman R., Cash R., Lhermitte F., and Javoy-Agid F. Parkinson's disease and dementia. Clinical Neuropharmacology 9 (1986) S22-S36
4. Alexander G.E., DeLong M.R., and Strick P.L. Parallel organization of functionally segregated circuits linking basal ganglia and cortex. Annual Review of Neuroscience 9 (1986) 357-381
5. Alexander K.R., Derlacki D.J., Fishman G.A., and Peachey N.S. Acuity-luminance and foveal increment threshold functions in retinitis pigmentosa. Investigative Ophthalmology and Visual Science 32 (1991) 1446-1454
6. Altman J. A biological view of drug abuse. Molecular Medicine Today 2 (1996) 237-241
7. Amick M.M., Cronin-Golomb A., and Gilmore G.C. Visual processing of rapidly presented stimuli is normalized in Parkinson's disease when proximal stimulus strength is enhanced. Vision Research 43 (2003) 2827-2835
8. Anderson R.E., and Maude M.B. Lipids of ocular tissues. 8. The effects of essential fatty acid deficiency on the phospholipids of the photoreceptor membranes of rat retina,. Archives of Biochemistry and Biophysics 151 (1972) 270-276
9. Anonymous. Essential fatty acid deficiency and the photoreceptors of rat retina. Nutrition Reviews 32 (1974) 342-345
10. Ball K., and Sekuler R. Improving visual perception in older observers. Journal of Gerontology 41 (1986) 176-182
11. Ball K., Beard B.L., Roenker D.L., Miller R.L., and Griggs D.S. Age and visual search: expanding the useful field of view. Journal of the Optical Society of America A: Optics and Image Science 5 (1988) 2210-2219
12. Barlett H., and Eperjesi F. Age-related macular degeneration and nutritional supplementation: a review of randomized controlled trials. Ophthalmic and Physiological Optics 23 (2003) 383-399
13. Bartel P., Blom M., Robinson E., Van der Meyden C., Sommers Dek., and Becker P. Effects of chlorpromazine on pattern and flash ERGs and VEPs compared to oxazepam and to placebo in normal subjects. Electroencephalography and Clinical Neurophysiology 77 (1990) 330-339
14. Bartel P., Blom M., Robinson E., Van der Meyden C., Sommers Dek., and Becker P. The effects of levodopa and haloperidol on flash and pattern ERGs and VEPs in normal humans. Documenta Ophthalmologica 76 (1990) 55-64
15. Behrens U., and Wagner H.J. Terminal nerve and vision. Microscopy Research and Technique 65 (2004) 25-32
16. Behrens U.D., Douglas R.H., Sugden D., Davies D.J., and Wagner H.J. Effect of melatonin agonists and antagonists on horizontal cell spinule formation and dopamine release in a fish retina. Cell Tissue Research 299 (2000) 299-306
17. Birch J., Kolle R.U., Kunkel M., Paulus W., and Upadhay P. Acquired colour deficiency in patients with Parkinson's disease. Vision Research 38 (1998) 3421-3426
18. Birch E.E., Garfield S., Castaneda Y., Hughbanks-Wheaton D., Uauy R., and Hoffman D. Visual acuity and cognitive outcomes at 4 years of age in a double-blind, randomized trial of long-chain polyunsaturated fatty acid-supplementation infant formula. Early Human Development 83 (2007) 279-284
19. Bird A.C. Clinical aspects: outer retinal dystrophies. In: Djamgoz M.B.A., et al. (Ed). Neurobiology and Clinical Aspects of the Outer Retina (1995), Chapman and Hall, London 417-446
20. Bird A.E.C., Bressler N.M., Bressler S.B., Chisholm I.H., Coscas G., Davis M.D., Dejong P., Klaver C.C.W., Klein B.E.K., Klein R., Mitchell P., Sarks J.P., Sarks S.H., Sourbane G., Taylor H.R., and Vingerling J.R. An international classification and grading system for age-related maculopathy and age-related macular degeneration. Survey of Ophthalmology 39 (1995) 367-374
21. Bjelke B., Goldstein M., Tinner B., Andersson C., Sesack S.R., Steinbusch H.W.M., Lew J.Y., He X., Watson S., Tengroth B., and Fuxe K. Dopaminergic transmission in the rat retina: evidence for volume transmission. Journal of Chemical Neuroanatomy 12 (1996) 37-50
22. Blin O., Mestre D., Masson G., and Serratrice G. Selective effects of low doses of apomorphine on spatiotemporal contrast sensitivity in healthy volunteers: a double-blind placebo-controlled study. British Journal of Clinical Pharmacology 32 (1991) 551-556
23. Bodis-Wollner I. Altered spatio-temporal contrast vision in Parkinson's disease and MPTP-treated monkeys: the role of dopamine. In: Bodis-Wollner I., et al. (Ed). Dopaminergic Mechanisms in Vision (1988), A.R. Liss Inc., New York 205-220
24. Bodis-Wollner I. The visual system in Parkinson's disease. In: Cohen B., et al. (Ed). Vision and the Brain (1990), Raven Press Ltd, New York 297-315
25. Bodis-Wollner I. Visual deficits related to dopamine deficiency in experimental animals and Parkinson's disease patients. Trends in Neuroscience 13 (1990) 296-302
26. Bodis-Wollner I., and Tagliati M. The visual system in Parkinson's disease. Advances in Neurology 60 (1993) 390-394
27. Bodis-Wollner I., and Tzelepi A. The push-pull action of dopamine on spatial tuning of the monkey retina: the effects of dopaminergic deficiency and selective D1 and D2 receptor ligands on the pattern electroretinogram. Vision Research 38 (1998) 1479-1487
28. Bodis-Wollner I., and Yahr M.D. Measurements of visual evoked potentials in Parkinson's disease. Brain 101 (1976) 661-671
29. Bodis-Wollner I., Yahr M.D., Mylin L., and Thornton J. Dopaminergic deficiency and delayed visual evoked potentials in humans. Annals of Neurology 11 (1982) 478-483
30. Bodis-Wollner I., Onofrj M.C., Marx M.S., and Mylin L.M. Visual evoked potentials in Parkinson's disease: spatial frequency, temporal rate, contrast, and the effect of dopaminergic drugs. In: Bodis-Wollner I., et al. (Ed). Evoked Potentials (1986), Alan R Liss Inc, New York 307-319
31. Bodis-Wollner I., Marx M.S., Mitra S., Bobak P., Mylin L., and Yahr M. Visual dysfunction in Parkinson's disease. Loss in spatiotemporal contrast sensitivity. Brain 110 (1987) 1675-1698
32. Bradley V.A., Welch J.L., and Dick D.J. Visuospatial working memory in Parkinson's disease. Journal of Neurology, Neurosurgery and Psychiatry 52 (1989) 1228-1235
33. Brandys Y., and Yehuda S. Indolamine hallucinations as MAO inhibitor agents-theoretical approach. International Journal of Neuroscience 21 (1983) 251-256
34. Bulens C., Meerwaldt J.D., Van der Wildt G.J., and Van Deursen J.B.P. Effect of Levodopa treatment on contrast sensitivity in Parkinson's disease. Annals of Neurology 22 (1987) 365-369
35. Bulens C., Meerwaldt J.D., and Van der Wildt G.J. Effect of stimulus orientation on contrast sensitivity in Parkinson's disease. Neurology 38 (1988) 76-81
36. Bulens C., Meerwaldt J.D., Van der Wildt G.J., and Keemink C.J. Visual contrast sensitivity in drug-induced parkinsonism. Journal of Neurology, Neurosurgery and Psychiatry 52 (1989) 341-345
37. Burton K.B., Owsley C., and Sloane M.E. Aging and neural contrast sensitivity: photopic vision. Vision Research 33 (1993) 939-946
38. Buttner T., Kuhn W., Patzold T., and Przuntek H. L-dopa improves colour vision in Parkinson's disease. Journal of Neural Transmission Parkinson's Disease and Dementia Section 7 (1994) 13-19
39. Buttner T., Kuhn W., Muller T., Patzold T., Heidbrink K., and Przuntek H. Distorted color discrimination in 'de novo' Parkinsonian patients. Neurology 45 (1995) 386-387
40. Buttner T., Kuhn W., Muller T., Patzold T., and Przuntek H. Color vision in Parkinson's disease: missing influence of amantadine sulphate. Clinical Neuropharmacology 18 (1995) 458-463
41. Buttner T., Muller T., and Kuhn W. Effects of apomorphine on visual functions in Parkinson's disease. Journal of Neural Transmission 107 (2000) 87-94
42. Calvert J.E., Harris J.P., and Phillipson O.T. Effects of L-dopa on the tilt after effect with differing stimulus contrast and test duration. Clinical Vision Science 5 (1990) 87-93
43. Calvert J.E., Harris J.P., and Phillipson O.T. Probing the visual system of Parkinson's disease and chronic schizophrenic patients on depot neuroleptic using the tilt after effect. Clinical Vision Science 7 (1992) 119-127
44. Cegalis J.A., and Deptula D. Attention in schizophrenia: Signal detection in the visual periphery. Journal of Nervous and Mental disease 169 (1981) 751-760
45. Chapman J. The early symptoms of schizophrenia. British Journal of Psychiatry 112 (1966) 225-251
46. Chase T.N., Burrows G.H., and Mohr E. Cortical glucose utilization patterns in primary degenerative dementias of the anterior and posterior type. Archives of Gerontology and Geriatrics 6 (1987) 289-297
47. Chui C.H., Mortimer J.A., Slager U., Zarow C., Bondareff W., and Webster D.D. Pathologic correlates of dementia in Parkinson's disease. Archives of Neurology 43 (1986) 991-995
48. Cogan D.G. Visual disturbances with focal progressive dementing disease. American Journal of Ophthalmology 100 (1985) 68-72
49. Cohen J.L., and Dowling J.E. The role of the retinal interplexiform cell: effects of 6-hydroxydopamine on the spatial properties of carp horizontal cells. Brain Research 264 (1983) 307-310
50. Connor W.E., Neuringer M., Barstad L., and Lin D.S. Dietary deprivation of linolenic acid in rhesus monkeys: effects of plasma and tissue fatty acid composition and on visual function. Transactions of the Association of American Physicians 91 (1984) 1-9
51. Coon S.L., del Olmo E., Scott Young III W., and Klein D.C. Melatonin synthesis enzymes in Macaca mulatta: Focus on arylalkylamine N-acetyltransferase (EC 2.3.1.87). Journal of Clinical Endocrinology and Metabolism 87 (2002) 4699-4706
52. Coppinger N.W. The relationship between critical flicker frequency and chronological age foe varying levels of stimulus brightness. Journal of Gerontology 10 (1955) 48-52
53. Corbe C., Arnaud F., Brault Y., and Janiak-Bolzinger C. Effect of dopaminergic agonist, piribedil (trivastal 50 mg LP), on visual and spatial integration in elderly subjects. Journal of Neurology 239 (1992) S22-S27
54. Corin M.S., Elizan T.S., and Bender M.B. Oculomotor function in patients with Parkinson's disease. Journal of Neurological Science 15 (1972) 251-265
55. Crawford T.J., Henderson L., and Kennard C. Abnormalities of nonvisually-guided eye movements in Parkinson's disease. Brain 112 (1989) 1573-1586
56. Cronin-Golomb A., Corkin S., Rizzo J.F., Cohen J., Growdon J.H., and Banks K.S. Visual dysfunction in Alzheimer's disease: relation to normal aging. Annals of Neurology 29 (1991) 41-52
57. Cronin-Golomb A., Corkin S., and Growdon J.H. Visual dysfunction predicts cognitive deficits in Alzheimer's disease. Optometry and Vision Science 72 (1995) 168-176
58. Crucian G.P., and Okun M.S. Visual-spatial ability in Parkinson's disease. Frontiers in Bioscience 8 (2003) 992-997
59. Curcio C.A., and Drucker D.N. Retinal ganglion cells in Alzheimer's disease and aging. Annals of Neurology 33 (1993) 248-257
60. Curcio C.A., Millican C.L., Allen K.A., and Kalina R.E. Aging of the human photoreceptor mosaic: evidence for selective vulnerability of rods in central retina. Investigative Ophthalmolology and Visual Science 34 (1993) 3278-3296
61. Dantzig P.I. Parkinson's disease, macular degeneration and cutaneous signs of mercury toxicity. Journal of Occupational and Environmental Medicine 48 (2006) 666
62. Delalande I., Hache J.C., Forzy G., Bughin M., Benhadjali J., and Destee A. Do visual-evoked potentials and spatiotemporal contrast sensitivity help to distinguish idiopathic Parkinson's disease and multiple system atrophy?. Movement Disorders 13 (1998) 446-452
63. Desai P., Roy M., Roy A., Brown S., and Smelson D. Impaired color vision in cocaine-withdrawn patients. Archives of General Psychiatry 54 (1997) 696-699
64. Diamond A., and Herzberg C. Impaired sensitivity to visual contrast in children treated early and continuously for phenylketonuria. Brain 119 (1996) 523-538
65. Diederich N.J., Raman R., Leurgans S., and Goetz C.G. Progressive worsening of spatial and chromatic processing deficits in Parkinson disease. Archives of Neurology 59 (2002) 1249-1252
66. Djamgoz M.B.A., and Wagner H.J. Localization and function of dopamine in adult vertebrate retina. Neurochemistry International 20 (1992) 139-191
67. Djamgoz M.B.A., Hankins M.W., Hirano J., and Archer S.N. Neurobiology of retinal dopamine in relation to degenerative states of the tissue. Vision Research 37 (1997) 3509-3529
68. Domenici L., Trimarchi C., Piccolino M., Fiorentini A., and Maffei L. Dopaminegic drugs improve human visual contrast sensitivity. Human Neurobiology 4 (1985) 195-197
69. Dong C.J., and McReynolds J.S. Comparison of the effects of flickering and steady light on dopamine release and horizontal cell coupling in the mudpuppy retina. Journal of Neurophysiology 67 (1992) 364-372
70. Dowling J.E. Retinal neuromodulation: the role of dopamine. Visual Neuroscience 7 (1991) 87-97
71. Drance S.M., Berry V., and Hughes A. Studies of the effects of age on the central and peripheral isopters of the visual field in normal subjects. American Journal of Ophthalmology 63 (1967) 1667-1672
72. Duchek J.M., Hunt L., Ball K., Buckles V., and Morris J.C. Attention and driving performance in Alzheimer's disease. Journals of Gerontology Series B: Psychological Sciences 53 (1998) 130-141
73. Dyer R.S., Howell W.E., and MacPhail R.C. Dopamine depletion slows retinal transmission. Experimental Neurology 71 (1981) 326-340
74. Ehle A.L., Stewart R.M., Lellelid N.E., and Leventhal N.A. Normal checkboard pattern reversal evoked potentials in parkinsonism. Electroencephalography and Clinical Neurophysiology 54 (1982) 336-338
75. Ellis C.J.K., and Ikeda H. Evidence for retinal dopamine deficiency in Parkinson's disease. In: Bodis-Wollner I., et al. (Ed). Dopaminergic Mechanism in Vision (1988), Alan R. Liss, New York 239-251
76. Ellis C.J.K., Allen T.G.L., Marsden C.D., and Ikeda H. Electroretinographic abnormalities in idiopathic Parkinson's disease and the effect of levodopa administration. Clinical Vision Science 1 (1987) 347-355
77. Enoch J.M., Lakshminarayanan V., Itzhaki A., Khamar B.M., Landau K., Lowe T., Surendran T., and Comerford J. Anomalous kinetic visual fields found in family members of patients with a confirmed diagnosis of Gilles de la Tourette syndrome. Optometry and Vision Science 68 (1991) 807-812
78. Ergun E., Maar N., Radner W., Barbazetto I., Schmidt-Erfurth U., and Stur M. Scotoma size and reading speed in patients with subfoveal occult choroidal neovascularization in age-related macular degeneration. Ophthalmology 110 (2003) 65-69
79. Ferris S., Reisberg B., Crook T., Friedman E., Schneck M.K., Sherman K.A., Corwin J., Gershon S., and Bartus R.T. Pharmacologic treatment of senile dementia: choline, L-dopa, piracetam and choline plus piracetam. In: Corkin S., et al. (Ed). Alzheimer's Disease: A Report Progress (1982), Raven Press, New York
80. Filip V., and Balik J. Possible indication of dopaminergic blockade in man by electroretinography. International Pharmacopsychiatry 13 (1978) 151-156
81. Frederick J.M., Rayborn M.E., Laties A.M., Lam D.M.K., and Holyfield J.G. Dopaminergic neurons in the human retina. Journal of Comparative Neurology 210 (1982) 65-79
82. Frucht Y., Vidauri J., and Melamed E. Light activation of dopaminergic neurons in rat retina is mediated through photoreceptors. Brain Research 249 (1982) 153-156
83. Futterman S., Downer J.L., and Hendrickson A. Effect of essential fatty acid deficiency on the fatty acid composition, morphology and electroretinographic response of the Retina. Investigative Ophthalmology 10 (1971) 151-156
84. Gawel M.J., Das P., Vincent S., and Rose F.C. Visual and auditory evoked responses in patients with Parkinson's disease. Journal of Neurology, Neurosurgery and Psychiatry 44 (1981) 227-232
85. Gilmore G.C., Wenk H.E., Naylor L.A., and Stuve T.A. Motion perception and aging. Psychology and Aging 7 (1992) 654-660
86. Glagow M., and Ewert J.P. Increases of excitatory receptive fields of retinal ganglion cells in common toads under apomorphine are not associated with size preference in prey-snapping. Neuroscience Letters 173 (1994) 83-86
87. Glagow M., and Ewert J.P. Dopaminergic modulation of visual responses in toads. II. Influences of apomorphine on retinal ganglion cells and tectal cells. Journal of Comparative Physiology A: Sensory Neural and Behavioral Physiology 180 (1997) 11-18
88. Gotham A.M., Brown R.G., and Marsden C.D. 'Frontal' cognitive function in patients with Parkinson's disease 'on' and 'off' levodopa. Brain 111 (1988) 299-321
89. Gottlob I., and Stangler-Zuschrott E. Effect of levodopa on contrast sensitivity and scotomas in human amblyopia. Investigative Ophthalmology and Visual Science 31 (1990) 776-780
90. Gottlob I., Scneider E., Heider W., and Skrandies W. Alteration of visual evoked potentials and electroretinograms in Parkinson's disease. Electroencephalography and Clinical Neurophysiology 66 (1987) 349-357
91. Gottlob I., Weghaupt H., Vass C., and Auff E. Effect of levodopa on the human pattern electroretinogram and pattern visual evoked potentials. Graefe's Archive for Clinical and Experimental Ophthalmology 227 (1989) 421-427
92. Gottlob I., Charlier J., and Reinecke R.D. Visual acuities and scotomas after one week levodopa administration in human amblyopia. Investigative Ophthalmology and Visual Science 33 (1992) 2722-2728
93. Graham W.C., Crossman A.R., and Woodruff G.N. Autoradiographic studies in animal models of hemi-parkinsonism reveal dopamine D2 but not D1 receptor supersensitivity. 1. 6-OHDA lesions o ascending mesencephalic dopaminergic pathways in the rat. Brain Research 514 (1990) 93-102
94. Guilardi M.F., Bodis-Wollner I., Onofrj M.C., Marx M.S., and Glover A.A. Spatial frequency-dependent abnormalities of the pattern electroretinogram and visual evoked potentials in a Parkinsonian monkey model. Brain 111 (1988) 131-149
95. Guilardi M.F., Marx M.S., Bodis-Wollner I., Camras C.B., and Glover A.A. The effect of intraocular 6-hydroxydopamine on retinal processing of primates. Annals of Neurology 25 (1989) 357-364
96. Haas A., Flammer J., and Schneider U. Influence of age on the visual fields of normal subjects. American Journal of Ophthalmology 101 (1986) 199-203
97. Haft M., and van Hemmen J.L. Theory and implementation of infomax filters for the retina. Neural Systems 9 (1998) 39-71
98. Hampson E.C.G.M., Vaney D.I., and Weiler R. Dopaminergic modulation of gap junction permeability between amacrine cells in mammalian retina. Journal of Neuroscience 12 (1992) 4911-4922
99. Harnois C., and Di Paolo T. Decreased dopamine in the retinas of patients with Parkinson's disease. Investigative Ophthalmology and Visual Science 31 (1990) 2473-2475
100. Harris J.P., Calvert J.E., Leendertz J.A., and Phillipson O.T. The influence of dopamine on spatial vision. Eye 4 (1990) 806-812
101. Harris J.P., Calvert J.E., and Phillipson O.T. Processing of spatial contrast in peripheral vision in Parkinson's disease. Brain 115 (1992) 1447-1457
102. Haug B.A., Trenkwalder C., Arden G.B., Oertel W.H., and Paulus W. Visual thresholds to low-contrast pattern displacement, color contrast, and luminance contrast stimuli in Parkinson's disease. Movement Disorders 9 (1994) 563-570
103. Haug B.A., Kolle R.U., Trenkwalder C., Oertel W.H., and Paulus W. Predominant affection of the blue cone pathway in Parkinson's disease. Brain 118 (1995) 771-778
104. Hikosaka O., and Wurtz R.H. Visual and oculomotor functions of monkey substantia nigra pars reticulate. IV. Rekation of substantia nigra to superior colliculus. Journal of Neurophysiology 49 (1983) 1285-1301
105. Hinton D.R., Sadun A.A., Blanks J.C., and Miller C.A. Optic-nerve degeneration in Alzheimer's disease. New England Journal of Medicine 315 (1986) 485-487
106. Hof P.R., Bouras C., Constantinidis J., and Morrison J.H. Balint's syndrome in Alzheimer's disease: Specific disruption of the occipito-parietal visual pathway. Brain Research 493 (1989) 368-375
107. Holopigian K., Clewner L., Seiple W., and Kupersmith M.J. The effects of dopamine blockade on the human flash electroretinogram. Documenta Ophthalmologica 86 (1994) 1-10
108. Hubel D.H., Wiesel T.N., and Stryker M.P. Anatomical demonstration of prientation columns in macaque monkey. Journal of Comparative Neurology 177 (1978) 361-380
109. Hunt L.A., Sadun A.A., and Bassi C.J. Review of the visual system in Parkinson's disease. Optometry and Vision Science 72 (1995) 92-99
110. Iudice A., Virgili P., and Muratorio A. The electroretinogram in Parkinson's disease. Research communications in Psychology. Psychiatry and Behavior 5 (1980) 283-289
111. Iuvone P., and Gan J. Functional interaction of melatonin receptors and D1 dopamine receptors in cultured chick retinal neurons. Journal of Neuroscience 15 (1995) 2179-2185
112. Iuvone P.M., Galli C.L., Garrison-Gund C.K., and Neff N.H. Light stimulates tyrosine hydroxylase activity and dopamine synthesis in retinal amacrine neurons. Science 202 (1978) 901-902
113. Iuvone P.M., Tigges M., Fernandes A., and Tigges J. Dopamine synthesis and metabolism in rhesus monkey retina: Development, aging, and the effects of monocular visual deprivation. Visual Neuroscience 2 (1989) 465-471
114. Iuvone P.M., Avendano G., Butler B.J., and Adler R. Cyclic AMP-dependent induction of serotonin N-acetyltransferase activity on photoreceptor-enriched chick retinal cell cultures: Characterization and inhibition by dopamine. Journal of Neurochemistry 55 (1990) 673-682
115. Jackson G.R., and Owsley C. Scotopic sensitivity during adulthood. Vision Research 40 (2000) 2467-2473
116. Jackson G.R., and Owsley C. Visual dysfunction, neurodegenerative diseases, and aging. Neurologic Clinics of North America 21 (2003) 709-728
117. Jackson G.R., Owsley C., and McGwin G. Aging and dark adaptation. Vision Research 39 (1999) 3975-3982
118. Jaffe M.J., Bruno G., Campbell G., Lavine R.A., Karson C.N., and Weinberger D.R. Ganzfeld electroretinographic findings in Parkinsonism: Untreated patients and the effect of levodopa intravenous infusion. Journal of Neurology, Neurosurgery and Psychiatry 50 (1987) 847-852
119. Jellinger K. Neuropathologcal substrates of Alzheimer's disease and Parkinson's disease. Journal of Neural Transmission 24 (1987) 109-129
120. Jensen R.J., and Daw N.W. Towards an understanding of the role of dopamine in the mammalian retina. Vision Research 23 (1983) 1293-1298
121. Jensen R.J., and Daw N.W. Effects of dopamine and its agonists and antagonists on the receptive field properties of ganglion cells in the rabbit retina. Neuroscience 17 (1986) 837-855
122. Kaas J.H. The structural basis for information processing in the primate visual system, Cambridge. Visual Neuroscience (1986) 315-340
123. Katz B., Rimmer S., Iragui V., and Katzman R. Abnormal pattern electroretinogram in Alzheimer's disease: evidence for retinal ganglion cell degeneration. Annals of Neurology 26 (1989) 221-225
124. Kelly D.H. Flickering patterns and lateral inhibition. Journal of the Optical Society of America 59 (1969) 1361-1370
125. Keri S., Kelemen O., Benedek G., and Janka Z. Vernier threshold in patients with schizophrenia and their unaffected siblings. Neuropsychology 18 (2004) 537-542
126. Klawans H.L., Falk D.K., Nausieda P.A., and Weiner W.J. Gilles de la Tourette syndrome after long-tem chlorpromazine therapy. Neurology 28 (1978) 1064-1068
127. Knoblauch K., Saunders F., Kusuda M., Hynes R., Podgor M., Higgins K.E., and de Monasterio F.M. Age and illuminance effects in the Farnsworth-Munsell 100-hue test. Applied Optics 26 (1987) 1441-1448
128. Koistinaho M., Ort M., Cimadevilla J.M., Vondrous R., Cordele B., Koistinaho J., Bures J., and Higgins L.S. Specific spatial learning deficits become severe with age in beta-amyloid precursor protein transgenic mice that harbor diffuse beta-amyloid deposits but do not form plaques. Proceedings of the National Academy of Sciences of the USA 98 (2001) 14675-14680
129. Korn H. The somatic component of schizophrenia: a dissociation of the goals of visual attention and bifoveal fixation. Medical Hypotheses 52 (1999) 163-170
130. Korn H. Further evidence for a reversed crossing of foveal projections in schizophrenic vulnerability. Medical Hypotheses 58 (2002) 305-311
131. Krizaj D., Akopian A., and Witkovsky P. The effects of l-glutamate, AMPA, quisqualate. and kainate on retinal horizontal cells depend on adaptational state: implications for rod-cone interactions. Journal of Neuroscience 14 (1994) 5661-5671
132. Kupersmith M.J., Shakin E., Siegel I.M., and Lieberman A. Visual system abnormalities in patients with Parkinson's disease. Archives of Neurology 39 (1982) 284-286
133. Kupersmith M.J., Seiple W.H., Nelson J.I., and Carr R.E. Contrast sensitivity loss in multiple sclerosis: Selectivity by eye, orientation, and spatial frequency measured ith the evoked potential. Investigative Ophthalmology and Visual Science 25 (1984) 632-639
134. Lakowski R. Is the deterioration of colour discrimination with age due to lens or retinal changes?. Die Farbe 11 (1962) 69-86
135. Langheinrich T., Tebartz van Elst L., Lagreze W.A., Bach M., Lucking C.H., and Greenlee M.W. Visual contrast response functions in Parkinson's disease: evidence from electroretinograms, visually evoked potentials and psychophysics. Clinical Neurophysiology 111 (2000) 66-74
136. Lazaruk L. Visuospatial impairment in persons with idiopathic Parkinson's disease: A literature review. Physical and Occupational Therapy in Geriatrics 12 (1994) 37-48
137. Lee J.Y., and Djamgoz M.B.A. Retinal dopamine depletion in young quail mimics some of the effects on ageing on visual function. Vision Research 37 (1997) 1103-1113
138. Lee A., and Harris J. Problems with perception of space in Parkinson's disease: a questionnaire study. Neuro-ophthalmology 22 (1999) 1-15
139. Leguire L.E., Rogers G.L., Bremer D.L., Walson P., and Wali N. Levodopa treatment for childhood amblyopia. Investigative Ophthalmology and Visual Science 32 suppl. (1991) 820
140. Lehman N.L., and Johnson L.N. Toxic optic neuropathy after concomitant use of melatonin, Zoloft, and a high-protein diet. Journal of Neuro-Ophthalmology 19 (1999) 232-234
141. Levin B.E., Llabre M.M., Reisman S., Weiner W.J., Sanchez-Ramos J., Singer C., Gibson J.M., Pimlott R., and Kennard C. Ocular motor and manual tracking in Parkinson's disease and the effect of treatment. Journal of Neurology, Neurosurgery and Psychiatry 50 (1987) 853-860
142. Levine D.N., Lee J.M., and Fisher C.M. The visual variant of Alzheimer's disease: a clinico-pathologic case study. Neurology 43 (1993) 305-313
143. Logi F., Pellegrinetti A., Bonfiglio L., Baglini O., Siciliano G., Iudice A., and Sartucci F. Effects of grating spatial orientation on visual evoked potentials and contrast sensitivity in multiple sclerosis. Acta Neurologica Scandinavica 103 (2001) 97-104
144. Luibl V., Isas J.M., Kayed R., Glabe C.G., Langen R., and Chen J. Drusen deposits associated with aging and age-related macular degeneration contain nonfibrillar amyloid oligomers. Journal of Clinical Investigation 116 (2006) 378-385
145. Madden D.J., and Greene H.A. From retina to response: Contrast sensitivity and memory retrieval during visual word recognition. Experimental Aging Research 13 (1987) 15-21
146. Mangel S.C., and Dowling J.E. The interplexiform-horizontal cell system of the fish retina: Effects of dopamine, light stimulation and time in the dark. Proceedings of the Royal Society of London, Series B, Biological Sciences 231 (1987) 91-121
147. Marx M., Bodis-Wollner I., Bobak P., Harnois C., Mylin L., and Yahr M. Temporal frequency-dependent VEP changes in Parkinson's disease. Vision Research 26 (1986) 185-193
148. Mashima Y., Sato E.A., Ohde H., and Oguchi Y. Macular nerve fibers temporal to fovea may have a greater potential to recover function in patients with Leber's hereditary optic neuropathy. Japanese Journal of Ophthalmology 46 (2002) 660-667
149. Masliah E., Rockenstein E., Veinbergs I., Mallory M., Hashimoto M., Takeda A., Sagara Y., Sisk A., and Mucke L. Dopaminergic loss and inclusion body formation in α-synuclein mice: implications for neurodegenerative disorders. Science 287 (2000) 1265-1269
150. Masson G., Mestre D., and Blin O. Dopaminergic modulation of visual sensitivity in man. Fundamentals of Clinical Pharmacology 7 (1993) 449-463
151. Melun J.P., Morin L.M., Muise J.G., and DesRosiers M. Color vision deficiencies in Gilles de la Tourette syndrome. Journal of the Neurological Sciences 186 (2001) 107-110
152. Mendez M.F., Mendez M.A., Martin R., Smyth K.A., and Whitehouse P.J. Complex visual disturbances in Alzheimer's disease. Neurology 40 (1990) 439-443
153. Mendez M.F., Tomsak R.L., and Remler B. Disorders of the visual system in Alzheimer's disease. Journal of Clinical Neuro-Ophthalmology 10 (1990) 62-69
154. Mestre D., Blin O., Serratrice G., and Pailhous J. Spatiotemporal contrast sensitivity differs in normal aging and Parkinson's disease. Neurology 40 (1990) 1710-1714
155. Mestre D., Blin O., Serratrice G., and Pailhous J. Human spatiotemporal contrast sensitivity: dopaminergic induced variations. European Journal of Pharmacology 183 (1990) 1022-1023
156. Mohr E., Fabbrini G., Williams J., Schlegel J., Cox C., Fedio P., and Chase T.N. Dopamine and memory function in Parkinson's disease. Movement Disorders 4 (1989) 113-120
157. Mohr E., Litvan I., Williams J., Fedio P., and Chase T.N. Selective deficits in Alzheimer and Parkinsonian dementia: visuospatial function. Canadian Journal of Neurological Sciences 17 (1990) 292-297
158. Mowry E.M., Balcer L.J., and Galetta S.L. Multiple sclerosis and the ophthalmologist. Comprehensive Ophthalmology Update 8 (2007) 39-49
159. Muir J.A., Barlow H.L., and Morrison J.D. Invariance of the pattern electroretinogram evoked by psychophysically equivalent stimuli in human ageing. Journal of Physiology 497 (1996) 825-835
160. Murayama K., Adachi-Uami E., and Yamada Y. Effects of L-dopa on electroretinographic responses and pattern visual evoked potentials in juvenile Parkinsonism. Clinical Vision Science 4 (1989) 265-268
161. Neuringer M., Connor W.E., Lin D.S., Barstad L., and Luck S. Biochemical and functional effects of prenatal and postnatal ω3 fatty acid deficiency on retina and brain in rhesus monkeys. Proceedings of the national Academy of Sciences of the USA 83 (1986) 4021-4025
162. Nguyen-Legros J., Harnois C., Di Paolo T., and Simon A. The retinal dopamine system in Parkinson's disease. Clinical Vision Science 8 (1993) 1-12
163. Nguyen-Legros J., Versaux-Botteri C., and Vernier P. Dopamine receptor localization in the mammalian retina. Molecular Neurobiology 19 (1999) 181-204
164. Nightingale S., Mitchell K.W., and Howe J.W. Visual evoked cortical potentials and pattern electroretinograms in Parkinson's disease and control subjects. Journal of Neurology, Neurosurgery and Psychiatry 49 (1986) 1280-1287
165. Nilsson U.L., Frennesson C., and Nilsson S.E.G. Patients with AMD and large absolute central scotoma can be trained successfully to use eccentric viewing, as demonstrated in a scanning laser ophthalmoscope. Vision Research 43 (2003) 1777-1787
166. Nir I., and Iuvone P.M. Alterations in light-evoked dopamine metabolism in dystrophic retinas of mutant rds mice. Brain Research 649 (1994) 85-94
167. Nissen M.J., Corkin S., Buonanno F.S., Growdon J.H., Wray S.H., and Bauer J. Spatial vision in Alzheimer's disease. Archives of Neurology 42 (1985) 667-671
168. Oades R.D. The role of noradrenaline in tuning and dopamine in switching between signals in the CNS. Neuroscience and Biobehavioral Reviews 9 (1985) 261-282
169. Obayashi S., Matsushima E., Ando H., Ando K., and Kojima T. Exploratory eye movements during the Benton visual retention test: characteristics of visual behavior in schizophrenia. Psychiatry and Clinical Neurosciences 57 (2003) 409-415
170. Owsley C., Sekuler R., and Siemsen D. Contrast sensitivity throughout adulthood. Vision Research 23 (1983) 689-699
171. Papadopoulos G.C., and Parnavelas J.G. Distribution and synaptic organization of dopaminergic axons in the lateral geniculate nucleus of the rat. Journal of Comparative Neurology 294 (1990) 356-361
172. Parkinson D. Evidence for a dopaminergic innervation of cat primary visual cortex. Neuroscience 30 (1989) 171-179
173. Parkinson D., and Randot R.R. Effect of light on dopamine turn-over and metabolism in rabbit retina. Investigative Ophthalmology and Visual Science 24 (1983) 384-388
174. Paulus W., Schwarz G., Werner A., Lange H., Bayer A., Hofschuster M., Muller N., and Zrenner E. Impairment of retinal increment thresholds in Huntington's disease. Annals of Neurology 34 (1993) 574-578
175. Pendrak K., Nguyen T., Lin T., Capehart C., Zhu X., and Stone R.A. Retinal dopamine in the recovery from experimental myopia. Current Eye Research 16 (1997) 152-157
176. Peppe A., Stanzione P., Pierelli F., Stefano E., Rizzo P.A., Tagliat M., and Morocutti C. Low contrast stimuli enhance PERG sensitivity to the visual dysfunction in Parkinson's disease. Electroencephalography and Clinical Neurophysiology 82 (1992) 453-457
177. Peppe A., Stanzione P., Pierantozzi M., Semprini R., Bassi A., Santilli A.M., Formisano R., Piccolono M., and Bernardi G. Does pattern electroretinogram spatial tuning alteration in Parkinson's disease depend on motor disturbances or retinal dopaminergic loss?. Electroencephalography and Clinical Neurophysiology 106 (1998) 374-382
178. Perry E.K. The cholinergic hypothesis-ten years on. British Medical Bulletin 42 (1986) 63-69
179. Phillipson O.T., and Harris J.P. Perceptual changes in schizophrenia: a questionnaire survey. Psychological Medicine 15 (1985) 859-866
180. Phillipson O.T., McKeown J.M., Baker J., and Healey A.F. Correlations between plasma chlorpromazine and its metabolites and clinical ratings in patients with acute relapse of schizophrenia and paranoid psychosis. British Journal of Psychiatry 131 (1977) 172-184
181. Plude D.J., and Hoyer W.J. Age and the selectivity of visual information processing. Psychology and Aging 1 (1986) 4-10
182. Price M.J., Feldman R.G., Adelberg D., and Kayne H. Abnormalities in color vision and contrast sensitivity in Parkinson's disease. Neurology 42 (1992) 887-890
183. Rascol O., Clanet M., Montastruc J.L., Simonetta M., Soulier-Esteve M.J., Doyon B., and Rascol A. Abnormal ocular movements in Parkinson's disease: evidence for involvement of dopaminergic systems. Brain 112 (1989) 1193-1214
184. Reader T.A., and Quesney L.F. Dopamine in the visual cortex of the cat. Experimentia 42 (1986) 1242-1244
185. Regan D., and Maxner C. Orientation-selective visual loss in patients with Parkinson's disease. Brain 110 (1987) 415-432
186. Regan D., and Neima D. Visual fatigue and visual evoked potentials in multiple sclerosis, glaucoma, ocular hypertension and Parkinson's disease. Journal of Neurology, Neurosurgery and Psychiatry 47 (1984) 673-678
187. Regan D., and Neima D. Low-contrast letter charts in early diabetic retinopathy, ocular hypertension, glaucoma, and Parkinson's disease. British Journal of Ophthalmology 68 (1984) 885-889
188. Regan B.C., Freudenthaler N., Kolle R., and Mollon J.D. Colour discrimination thresholds in Parkinson's disease: results obtained with a rapid computer-controlled colour vision test. Vision Research 38 (1998) 3427-3431
189. Reifsnider E.S., and Tranchina D. Background contrast modulates kinetics and lateral spread of responses to superimposed stimuli in outer retina. Visual Neuroscience 12 (1995) 1105-1126
190. Reis R.A.M., Ventura A.L.M., Kubrusly R.C.C., de Mello M.C.F., and de Mello F.G. Dopaminergic signaling in the developing retina. Brain Research Reviews 54 (2007) 181-188
191. Reitsamer H.A., Pflug R., Franz M., and Huber S. Dopaminergic modulation of horizontal-cell-axon-terminal receptive field size in the mammalian retina. Vision Research 46 (2006) 467-474
192. Rizzo M., and Nawrot M. Perception of movement and shape in Alzheimer's disease. Brain 121 (1998) 2259-2270
193. Rizzo III J.F., Cronin-Golomb A., Growdon J.H., Corkin S., Rosen T.J., Sandberg M.A., Chiappa K.H., and Lessell S. Retinocalcarine function in Alzheimer's disease: a clinical and electrophysiological study. Archives of Neurology 49 (1992) 93-101
194. Robson J.G. Spatial and temporal contrast-sensitivity functions of the visual system. Journal of the Optical Society of America 56 (1966) 1141-1142
195. Roy M., Roy A., Williams J., Weiberger L., and Smelson D. Reduced blue cone electroretinogram in cocaine-withdrawn patients. Archives of General Psychiatry 54 (1997) 153-156
196. Sahakian B.J., Morris R.G., Evenden J.L., Heald A., Levy R., Philpot M., and Robbins T.W. A comparative study of visuospatial memory and learning in Alzheimer-type dementia and Parkinson's disease. Brain 111 (1988) 695-718
197. Salthouse T.A. Speed mediation of adult age differences in cognition. Developmental Psychology 29 (1993) 722-738
198. Sannita W.G. Electrophysiology of the visual system: from neuroscience to human neuropharmacology. Neuropsychobiology 32 (1995) 208-213
199. Schechter I., Butler P.D., Silipo G., Zemon V., and Javitt D.C. Magnocellular and parvocellular contributions to backward masking dysfunction in schizophrenia. Schizophrenia Research 64 (2003) 91-101
200. Schlotterer G., Moscovitch M., and Crapper-McLaclan D. Visual processing deficits as assessed by spatial frequency contrast sensitivity and backward masking in normal ageing and Alzheimer's disease. Brain 107 (1983) 309-325
201. Schorderet M., and Nowak J.Z. Retinal dopamine D1 and D2 receptors: characterization by binding or pharmacological studies and physiological functions. Cellular and Molecular Neurobiology 10 (1990) 303-325
202. Seeman P. Brain dopamine receptors in schizophrenia and tardive dyskinesia. Psychopharmacology 2 suppl. (1985) 1-8
203. Sekular R., and Picciano Hutman L. Spatial vision and aging. I: contrast sensitivity. Journal of Gerontology 35 (1980) 692-699
204. Serra A., Derwenskus J., Downey D.L., and Leigh R.J. Role of eye movement examination and subjective visual vertical in clinical evaluation of multiple sclerosis. Journal of Neurology 250 (2003) 569-575
205. Shuwairi S.M., Cronin-Golomb A., McCarley R.W., and O'Donnell B.F. Color discrimination in schizophrenia. Schizophrenia Research 55 (2002) 197-204
206. Singer H.S., and Walkup J.T. Tourette syndrome and other tic disorders. Diagnosis, pathophysiology and treatment. Medicine 70 (1991) 15-32
207. Singer H.S., Butler I.J., Tune L.E., Seifer W.E., and Coyle J.T. Dopaminergic dysfunction in Tourette's syndrome. Annals of Neurology 12 (1982) 361-366
208. Singer H.S., Hahn I.H., and Moran T.H. Abnormal dopamine uptake sites in postmortem striatum from patients with Tourette's syndrome. Annals of Neurology 30 (1991) 558-562
209. Sloane M.E., Owsley C., and Jackson C.A. Aging and luminance-adaptation effects in spatial contrast sensitivity. Journal of the Optical Society of America A: Optics and Image Science 5 (1988) 2181-2190
210. Smith P., Sharma S., and Steinle J.J. Age-related changes in sympathetic neurotransmission in rat retina and choroid. Experimental Eye Research 84 (2007) 75-81
211. Stanzione P., Pierelli F., Peppe A., Stefano E., Rizzo P.A., Morocutti C., and Bernardi G. Pattern visual evoked potentials and electroretinogram abnormalities in Parkinson's disease: effects of L-dopa therapy. Clinical Vision Science 4 (1989) 115-127
212. Stanzione P., Fattapposta F., Tagliati M., D'Alessio C., Marciani M.G., Foti A., and Amabile G. Dopaminergic Pharmacological manipulations in normal humans confirm the specificity of the visual (PERG_VEP) and cognitive (P300) electrophysiological alterations on Parkinson's disease. In: Rossini P.M., et al. (Ed). New Trends and Advanced Techniques in Clinical Neurophysiology (EEG Suppl. 41) (1990), Elsevier Science Publishers B.V. (Biomedical Division) 216-220
213. Stanzione P., Tagliati M., Pierantozzi M., and Bodis-Wollner I. The role of D2 receptors in retinal processing in humans. Annals of Neurology 30 (1991) 256
214. Stanzione P., Traversa R., Pierantozzi M., Semprini R., Marciani M.G., and Bernardi G. An electrophysiological study of D2 dopaminergic actions in normal human retina: a tool in Parkinson's disease. Neuroscience Letters 136 (1992) 125-128
215. Stein L., Belluzzi J.D., and Wise C.D. Memory enhancement by central administration of norepinephrine. Brain Research 84 (1975) 329-335
216. Sugawara T., Sieving P.A., Iuvone P.M., and Bush R.A. The melatonin antagonist luzindole protects retinal photoreceptors from light damage in the rat. Investigative Ophthalmology and Visual Science 39 (1998) 2458-2465
217. Tagliati M., Bodis-Wollner I., Kovanecz I., and Stanzione P. Spatial frequency tuning of the monkey pattern ERG depends on D2 receptor-linked action of dopamine. Vision Research 34 (1994) 2051-2057
218. Thaker G.K., Ross D.E., Cassady S.L., Adami H.M., LaPorte D., Medoff D.R., and Lahti A. Smooth pursuit eye movements to extraretinal motion signals. Deficits in relatives of patients with schizophrenia,. Archives of General Psychiatry 55 (1998) 830-836
219. Trick G.L., Barris M.C., and Bickler-Bluth M. Abnormal pattern electroretinogram in patients with senile dementia of the Alzheimer's type. Annals of Neurology 26 (1989) 226-231
220. Trick G.L., Kaskie B., and Steinman S.B. Visual impairment in Parkinson's disease: deficits in orientation and motion discrimination. Optometry and Vision Science 71 (1994) 242-245
221. Vinton N.E., Heckenlively J.R., Laidlaw S.A., Martin D.A., Foxman S.R., Ament M.E., and Kopple J.D. Visual function in patients undergoing long-term total parenteral nutrition. American Journal of Clinical Nutrition 52 (1990) 895-902
222. Wagner H.J., Behrens U.D., Zaunreiter M., and Douglas R.H. The circadian component of spinule dynamics in teleost retinal horizontal cells is dependent on the dopaminergic system. Visual Neuroscience 9 (1992) 345-351
223. Waldo M.C., Adler L.E., Leonard S., Olincy A., Ross R.G., Harris J.G., and Freedman R. Familial transmission of risk factors in the first-degree relatives of schizophrenic people. Biological Psychiatry 47 (2000) 231-239
224. Waterfall M., and Crowe S.F. Meta-analytic comparison of the components of visual cognition in Parkinson's disease. Journal of Clinical and Experimental Neuropsychology 17 (1995) 759-772
225. Weale R.A. Senile changes in vision acuity. Transactions of the Ophthalmological Societies of the UK 95 (1975) 36-38
226. Weiler R., and Akopian A. Effects of background illuminations on the receptive field size of horizontal cells in the turtle retina are mediated by dopamine. Neuroscience Letters 140 (1992) 121-124
227. Wink B., and Harris J. A model of the Parkinsonian visual system: support for the dark adaptation hypothesis. Vision Research 40 (2000) 1937-1946
228. Witkovsky P. Dopamine and retinal function. Documenta Ophthalmologica 108 (2004) 17-40
229. Witkovsky P., and Dearry A. Functional roles of dopamine in the vertebrate retina. Progress in Retinal Research 11 (1992) 247-292
230. Witkovsky P., Arango-Gonzalez B., Haycock J.W., and Kohler K. Rat retinal dopaminergic neurons: differential maturation of somtodendritic and axonal compartments. Journal of Comparative Neurology 481 (2005) 352-362
231. Wolf E. Glare and age. Archives of Ophthalmology 64 (1960) 502-514
232. Wright C.E., and Drasdo N. The influence of age on the spatial and temporal contrast sensitivity function. Documenta Ophthalmologica 59 (1985) 385-395
233. Xin D., and Bloomfield S.A. Effects of nitric oxide on horizontal cells in the rabbit retina. Visual Neuroscience 17 (2000) 799-811
234. Zrenner E., Nowicki J., and Adamczyk R. Cone function and cone interaction in hereditary degenerations of the central retina. Documenta Ophthalmologica 62 (1986) 5-12